• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: IPG MFG SWITZERLAND KINETRA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

IPG MFG SWITZERLAND KINETRA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR Back to Search Results
Model Number 7428
Device Problems High impedance (1291); Unable to Obtain Readings (1516); Device Displays Incorrect Message (2591)
Patient Problem Therapeutic Effects, Unexpected (2099)
Event Date 11/01/2014
Event Type  Injury  
Event Description
Additional information reported ¿it was possible to stimulate with normal stim-parameters¿ with the patient¿s replacement ins and that the patient received ¿effective stimulation" following the replacement.
 
Manufacturer Narrative
Analysis of the implantable neurostimulator (ins) found the battery was at normal end of life and telemetry and output were okay.The charge density warning was confirmed on the ins during analysis.According to the manual a charge density warning will appear if the charge density is above 30 microcoulombs/cm2/phase, which is based on the amplitude and pulse width parameter settings.The charge density warning will appear if the programmed amplitude or the upper limit amplitude along with the pulse width creates a condition above 30 microcoulombs/cm2/phase.Even if the programmed amplitude is low and within the acceptable charge density condition, the warning will still appear if the upper limit is programmed above the acceptable charge density condition.As received for analysis, this ins had the patient control upper limit set to a custom setting of 4.5 volts and a pulse width of 210 ¿s which was high enough to cause the charge density warning to appear even though the programmed amplitude was low.This is normal function for a kinetra ins when using a custom amplitude limit above the acceptable charge density condition, because leaving it in this condition would allow the patient with a patient programmer to set the device to an amplitude above an acceptable charge density condition.
 
Event Description
It was reported that interrogation of the patient¿s implantable neurostimulator (ins) with a physician programmer ¿showed a charge density warning although the stimulation parameters were far beyond the warning limit.¿ it was stated there were ¿stimulation/therapy issues¿ with ¿less than 50% therapy relief¿ at an unknown location.Ongoing troubleshooting was being performed due to the event at the time of initial report.The patient was alive with no injury at the time of report.It was noted the patient¿s right electrode was positioned in their subthalamic nucleus (stn).Impedance testing found that unipolar electrodes 6 and 7 (on the patient¿s left half) had impedances ¿>4000¿ ohms when tested at 3 volts.Interrogation records indicated the patient¿s right half therapeutic impedance was ¿>4000¿ ohms and the left half returned a ¿???¿ impedance value.It was noted the patient¿s left half was ¿not included in the therapy¿ and was ¿set to 0 volts¿ while the patient¿s right half was set to 1 volt.The patient was reportedly ¿ok¿ 18 days after initial report, but their ¿therapy was not 100% effective.¿ the patient was noted to be scheduled to receive a ¿new ins¿ and undergo an additional impedance test and troubleshooting during an appointment scheduled for 2015-(b)(6).Additional information has been requested; a supplemental report will be filed if additional information is received.
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
Concomitant medical products: product id 74955136, serial# (b)(4), product type: extension.Product id 74955136, serial# (b)(4), product type: extension.Analysis results were not available as of the date of this report.A follow-up report will be submitted when analysis is complete.
 
Event Description
Additional information noted the patient had forgotten and conseuqent missed their (b)(6) 2015 scheduled operation.The patient's operation was rescheduled for (b)(6) 2015 as a result.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
KINETRA
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR
Manufacturer (Section D)
IPG MFG SWITZERLAND
route du molliau 31
tolochenaz MN 1131
CH  1131
Manufacturer (Section G)
MEDTRONIC NEUROMODULATION
7000 central avenue ne rcw215
minneapolis MN 55432
Manufacturer Contact
diane wolf
7000 central avenue ne rcw215
minneapolis, MN 55432
7635263987
MDR Report Key4362417
MDR Text Key5508725
Report Number3007566237-2014-03780
Device Sequence Number1
Product Code MHY
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P960009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,company representati
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 12/01/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/26/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/28/2010
Device Model Number7428
Device Catalogue Number7428
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/23/2015
Is the Reporter a Health Professional? No
Date Manufacturer Received04/08/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/05/2008
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-